Jasmijn F Timp

Learn More
Cancer-associated venous thrombosis is a common condition, although the reported incidence varies widely between studies depending on patient population, start and duration of follow-up, and the method of detecting and reporting thrombotic events. Furthermore, as cancer is a heterogeneous disease, the risk of venous thrombosis depends on cancer types and(More)
BACKGROUND Prediction of recurrent venous thrombosis remains a challenge in the clinic. OBJECTIVE To investigate the predictive value of coagulation factor VIII (FVIII) levels for recurrent venous thrombosis. PATIENTS/METHODS Patients, aged 18-70 years with a first venous thrombosis, were followed from discontinuation of anticoagulant treatment(More)
A role for transient infections in the aetiology of venous thrombosis (VT) has been suggested. This study aimed to determine whether individuals who receive antibiotic treatment (as a proxy for infections) have an increased risk of first and recurrent VT and whether infections should be seen as a provoking risk factor for VT. We used the self-controlled(More)
BACKGROUND Factor VIII (FVIII) levels are increased in individuals with a non-O blood group and play a role in the etiology of thrombosis. High FVIII levels have also been associated with increased all-cause mortality. OBJECTIVE We explored whether elevated FVIII levels are associated with an increased risk of death in patients who had venous thrombosis(More)
  • 1